HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Esophageal Stent Alleviates Benign Strictures

By HospiMedica International staff writers
Posted on 06 Mar 2014
Print article
Image: The WallFlex Nitinol esophageal stent (Photo courtesy of Boston Scientific).
Image: The WallFlex Nitinol esophageal stent (Photo courtesy of Boston Scientific).
A fully covered metal stent provides new treatment options for patients with benign narrowing of the esophagus.

The WallFlex esophageal stent is made of a nickel-titanium (Nitinol) wire braided construction that provides luminal patency in the presence of strictures or benign tumors. The stent is designed for gradual expansion, typically complete in 24-72 hours; it features a Permalume silicone coating that is designed to prevent tumor in-growth, seal concurrent esophageal fistulas, and help reduce food impaction. The WallFlex Stent also provides physicians with clear visualization during fluoroscopy, aiding in accurate placement, as well as progressive, step flared ends that assist in anchoring the stent within the esophageal lumen.

An additional feature is a Teflon coated polyester suture that enables easy removal for up to eight weeks, potentially saving patients from having to visit the hospital to undergo additional dilations. The WallFlex Esophageal Fully Covered Stent is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval. The stent is not approved for the removal from malignant strictures and has not been approved in the United States for the treatment of refractory benign esophageal strictures.

“Building on the best of Boston Scientific's industry-leading stents, the expanded indication for the WallFlex Esophageal Fully Covered Stent demonstrates our commitment to physician needs and dedication to improving patient outcomes,” said David Pierce, president of endoscopy at Boston Scientific. “This enables physicians in the European Union to provide additional options for the treatment and management of patients suffering from benign esophageal strictures.”

“Fully covered esophageal stents are a valid therapeutic option in patients with benign refractory esophageal strictures,” said Javier Jimenez, MD, chief of the Endoscopy Department at Complejo Hospitalario de Navarra (Pamplona, Spain). “I use the WallFlex Esophageal Stent because its small profile and radiopacity facilitate accurate placement, the migration rate is low, and stent removal is usually easy.”

Benign esophageal strictures are a narrowing or tightening of the esophagus caused by scarring that cause swallowing difficulties. Strictures can be caused by or associated with gastroesophageal reflux disease (GERD), esophagitis, a dysfunctional lower esophageal sphincter, disordered motility, lye ingestion, or a hiatal hernia. Strictures can also form after esophageal surgery and other treatments such as laser therapy or photodynamic therapy (PDT). The primary treatment is dilation of the esophagus, which may need to be repeated after a period if the stricture recurs.

Related Links:

Boston Scientific


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Illuminated Retractor System
HandLite

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more